亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

偽異沙蟾毒精 CAS號(hào):17008-65-0

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 陜西寶雞市付款后3天內(nèi)
品牌 herbest
型號(hào) 17008-65-0
規(guī)格 HPLC>98%
過(guò)期 長(zhǎng)期有效
更新 2013-08-06 14:48
 

寶雞市辰光生物科技有限公司.

企業(yè)會(huì)員第13年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明
 

中文名稱:偽異沙蟾毒精
英文名稱:bufarenogin
CAS號(hào):17008-65-0
純度:HPLC>98%

 

詳細(xì)介紹:

分子量:416.50g/mol

分子式C24H32O6

別名:bufa-20,22-dienolide, 3,12,14-trihydroxy-11-oxo-,(3|A,5|A,12|A)-
Bufa-20,22-dienolide, 3,12,14-trihydroxy-11-oxo-, (3beta,5beta,12beta)-

外觀:白色結(jié)晶粉末

來(lái)源:蟾蜍科動(dòng)物如中華大蟾蜍Bufo bufo gargarizans Cantor 或黑眶蟾蜍 Bufo melanostictus Schneider 的干燥分泌物

包裝;20mg; 100mg,1g

貯存:2~8 ℃避光,干燥處

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
穿心蓮內(nèi)酯 CAS號(hào):5508-58-7 寶藿苷Ⅰ CAS號(hào):113558-15-9 金絲桃苷 CAS號(hào):482-36-0 CAS號(hào):465-21-4 蟾毒靈 葫蘆素E CAS號(hào):18444-66-1 CAS號(hào):568-72-9 丹參酮IIA CAS號(hào):118525-40-9 脫水淫羊藿素
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |